Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

Editor(s): Rogler G. (Zurich) 
Herfarth H. (Chapel Hill, N.C.) 
Hibi T. (Tokyo) 
Nielsen O.H. (Copenhagen) 

Status: available   
Publication year: 2015
Buy this book
Digital Version: CHF 198.00, EUR 185.00, USD 233.00
Print Version: CHF 198.00, EUR 185.00, USD 233.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.

This book belongs to
Frontiers of Gastrointestinal Research , Vol. 34
Editor(s): Rogler G. (Zurich) 
VIII + 240 p., 26 fig., 17 in color, 15 tab., hard cover, 2015
Status: available   
ISSN: 0302-0665
e-ISSN: 1662-3754

Read the reviews


'Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease besticht durch den weitreichend erfüllten Anspruch, die Lücke zwischen Grundlagen-Forschung und klinischem Einsatz zu überbrücken. Ferner punktet das Werk in Sachen Aktualität und Praxisnähe durch Einbau drängender Fragestellungen […] Mithin sei es einer breiten Leserschaft von klinischen Spezialisten und/oder Forschenden empfohlen, die sich schwerpunktmässig in diesem Gebiet bewegen.'

Vincent Zimmer

The first comprehensive overview on the topic
The introduction of anti-tumour necrosis factor (TNF) antibodies into the treatment of patients with IBD about fifteen years ago has dramatically improved the quality of life for patients with severe Crohn's disease and ulcerative colitis. But despite the fact this therapeutic approach has been around for quite some time, there has been no comprehensive overview to date.
The book at hand aims to amend this shortcoming, presenting for the first time a thorough overview on TNF action, mechanisms of anti-TNF therapy, treatment strategies, side effects, monitoring, biosimilars and related issues.
Including state-of-the-art information and research results, this publication will be a valuable source of information and guide clinicians to the optimal treatment decision, improving the quality of life of patients with inflammatory bowel disease. Moreover, rheumatologists or even dermatologists might also find this book of interest.